Acute Myeloid Leukemia-Pediatric, Adolescents and Young Adults
Back to Oncology/Cancer Clinical Trials Main PageCPMC Cancer Services
| Principal Investigator/Contact Information | Protocol Title | Patient Population | Recruitment Period |
| Principal Investigator: CPMC Oncologists Contact: Catherine Carr 415-600-1369 | Phase III Randomized Trial of Gemtuzumab Ozogamicin (Mylotarg®) Combined with Conventional Chemotherapy for De Novo Acute Myeloid Leukemia (AML) in Children, Adolescents, and Young Adults. AAML0531 Visit this study on ClinicalTrials.gov. | Children , adolescents and young adults with De Novo Acute Myeloid Leukemia | Open |
updated: 11/19/09
Back to top